Hope Kronman

Hope Kronman

Auto-generated profile, based on publicly available information

Hope Kronman

Department of Psychiatry at NYU Langone Medical Center, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BLBenoit Labonté
Benoit Labonté
OEOlivia Engmann
Olivia Engmann
IPImmanuel Purushothaman
Immanuel Purushothaman
CMCaroline Menard
Caroline Menard
JWJunshi Wang
Junshi Wang
ENEric J Nestler
Eric J Nestler

16 June 2017 in Science
Verified
Journal Article
Closed access
PDF file
CPCatherine J. Peña
Catherine J. Peña
HKHope G. Kronman
Hope G. Kronman
DWDeena M Walker
Deena M Walker
HCHannah M. Cates
Hannah M. Cates
RBRosemary C. Bagot
Rosemary C. Bagot
ENEric J Nestler
Eric J Nestler
Early life stress increases risk for depression. Here we establish a “two-hit” stress model in mice wherein stress at a specific postnatal period increases susceptibility to adult social defeat stress and causes long-lasting transcriptional alterations that prime the ventral tegmental area (VTA)—a brain reward region—to be in a depression-like state. We identify a role for the developmental transcription factor orthodenticle homeobox 2 (Otx2) as an upstream mediator of these enduring effects. Transient juvenile—but not adult—knockdown of Otx2 in VTA mimics early life stress by increasing stress susceptibility, whereas its overexpression reverses the effects of early life stress. This work establishes a mechanism by which early life stress encodes lifelong susceptibility to stress via long-lasting transcriptional programming in VTA mediated by Otx2.

10 August 2016 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
HKHee-Dae Kim
Hee-Dae Kim
JHJennifer Hesterman
Jennifer Hesterman
TCTanessa Call
Tanessa Call
SMSamantha Magazu
Samantha Magazu
EKElizabeth Keeley
Elizabeth Keeley
DFDeveroux Ferguson
Deveroux Ferguson
Depression is a recurring and life-threatening illness that affects up to 120 million people worldwide. In the present study, we show that chronic social defeat stress, an ethologically validated model of depression in mice, increases SIRT1 levels in the nucleus accumbens (NAc), a key brain reward region. Increases in SIRT1, a well characterized class III histone deacetylase, after chronic social defeat suggest a role for this enzyme in mediating depression-like behaviors. When resveratrol, a pharmacological activator of SIRT1, was directly infused bilaterally into the NAc, we observed an increase in depression- and anxiety-like behaviors. Conversely, intra-NAc infusions of EX-527, a SIRT1 antagonist, reduced these behaviors; EX-527 also reduced acute stress responses in stress-naive mice. Next, we increased SIRT1 levels directly in NAc by use of viral-mediated gene transfer and observed an increase in depressive- and anxiety-like behaviors when mice were assessed in the open-field, elevated-plus-maze, and forced swim tests. Using a Cre-inducible viral vector system to overexpress SIRT1 selectively in dopamine D1 or D2 subpopulations of medium spiny neurons (MSNs) in the NAc, we found that SIRT1 promotes depressive-like behaviors only when overexpressed in D1 MSNs, with no effect seen in D2 MSNs. Conversely, selective ablation of SIRT1 in the NAc using viral-Cre in floxed Sirt1 mice resulted in decreased depression- and anxiety-like behaviors. Together, these results demonstrate that SIRT1 plays an essential role in the NAc in regulating mood-related behavioral abnormalities and identifies a novel signaling pathway for the development of innovative antidepressants to treat major depressive disorders. SIGNIFICANCE STATEMENT In this study, we demonstrate a pivotal role for SIRT1 in anxiety- and depression-like behaviors in the nucleus accumbens (NAc), a key brain reward region. We show that stress stably induces SIRT1 expression in this brain region and that altering SIRT1 activity using a pharmacological or genetic approach regulates anxiety- and depression-like behaviors. These results suggest that SIRT1 plays an essential role in regulating mood-related behaviors and introduces a novel signaling pathway for the development of innovative antidepressants to treat depression and other stress-related disorders. A recent groundbreaking publication by the CONVERGE Consortium (2015) identified a reproducible association of the SIRT1 locus with major depression in humans. Therefore, our results are timely and have significant translational relevance.

11 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMelissa S. Monsey
Melissa S. Monsey
LBLara M. Boyle
Lara M. Boyle
MZMelinda L. Zhang
Melinda L. Zhang
CNCaroline P. Nguyen
Caroline P. Nguyen
HKHope G. Kronman
Hope G. Kronman
GSGlenn E. Schafe
Glenn E. Schafe
Chronic exposure to stress has been widely implicated in the development of anxiety disorders, yet relatively little is known about the long-term effects of chronic stress on amygdala-dependent memory formation. Here, we examined the effects of a history of chronic exposure to the stress-associated adrenal steroid corticosterone (CORT) on the consolidation of a fear memory and the expression of memory-related immediate early genes (IEGs) in the lateral nucleus of the amygdala (LA). Rats received chronic exposure to CORT (50 μg/ml) in their drinking water for 2 weeks and were then titrated off the CORT for an additional 6 days followed by a 2 week ‘wash-out’ period consisting of access to plain water. Rats were then either sacrificed to examine the expression of memory-related IEG expression in the LA or given auditory Pavlovian fear conditioning. We show that chronic exposure to CORT leads to a persistent elevation in the expression of the IEGs Arc/Arg3.1 and Egr-1 in the LA. Further, we show that rats with a history of chronic CORT exposure exhibit enhanced consolidation of a fear memory; short-term memory (STM) is not affected, while long-term memory (LTM) is significantly enhanced. Treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine following the chronic CORT exposure period was observed to effectively reverse both the persistent CORT-related increases in memory-related IEG expression in the LA and the CORT-related enhancement in fear memory consolidation. Our findings suggest that chronic exposure to CORT can regulate memory-related IEG expression and fear memory consolidation processes in the LA in a long-lasting manner and that treatment with fluoxetine can reverse these effects.

26 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
PMPhilipp Mews
Philipp Mews
YZYentl Van der Zee
Yentl Van der Zee
HKHope Kronman
Hope Kronman
AGAshik Gurung
Ashik Gurung
ARAarthi Ramakrishnan
Aarthi Ramakrishnan
ENEric J Nestler
Eric J Nestler
A hallmark of addiction is the ability of drugs of abuse to trigger relapse after periods of prolonged abstinence. Here, we describe a novel epigenetic mechanism whereby chronic cocaine exposure causes lasting chromatin and downstream transcriptional modifications in the nucleus accumbens (NAc), a critical brain region controlling motivation. We link prolonged withdrawal from cocaine to the depletion of the histone variant H2A.Z, coupled to increased genome accessibility and latent priming of gene transcription, in D1 dopamine receptor-expressing medium spiny neurons (D1 MSNs) that relates to aberrant gene expression upon drug relapse. The histone chaperone ANP32E removes H2A.Z from chromatin, and we demonstrate that D1 MSN-selective Anp32e knockdown prevents cocaine-induced H2A.Z depletion and blocks cocaine’s rewarding actions. By contrast, very different effects of cocaine exposure, withdrawal, and relapse were found for D2-MSNs. These findings establish histone variant exchange as an important mechanism and clinical target engaged by drugs of abuse to corrupt brain function and behavior.

8 September 2025 in Journal of Psychedelic Studies
Verified
Journal Article
Open access
PDF file
HKHope Kronman
Hope Kronman
ALAlison Locker
Alison Locker
AAAbdi Assadi
Abdi Assadi
JGJeffrey Guss
Jeffrey Guss
Psychedelic treatments like MDMA can sometimes have side effects which persist despite management with Western medical approaches. In what follows, we present a case study of an individual who suffered from insomnia, anxiety, tinnitus, and more for months following MDMA therapy. Ultimately, her symptoms responded to management within the Traditional Chinese Medicine framework. We present this case in detail, and argue that psychedelic management, especially in the integration phase, can benefit from the incorporation of techniques which engage with energies that Western medicine do not address.